Sign In to Follow Application
View All Documents & Correspondence
View All Documents & Correspondence
Biaryl Derivative As Gpr120 Agonist
Abstract: The present invention relates to a biaryl derivative expressed by the chemical formula 1 a method for producing the biaryl derivative a pharmaceutical composition comprising same and use of same the biaryl derivative expressed by the chemical formula 1 as a GPR120 agonist promoting GLP 1 generation in the gastro intestinal tract reducing insulin resistance in the liver muscles and the like from anti inflammatory activity in the macrophage pancreatic cells and the like and allowing effective use in prevention or treatment of inflammation or metabolic diseases such as diabetes complications from diabetes obesity non alcoholic fatty liver disease fatty liver disease and osteoporosis.
Get Free WhatsApp Updates!
Notices, Deadlines & Correspondence
Notices, Deadlines & Correspondence
Patent Information
Application #
Filing Date
19 July 2017
Publication Number
30/2017
Publication Type
INA
Invention Field
CHEMICAL
Status
Email
ipo@knspartners.com
Parent Application
Patent Number
Legal Status
Grant Date
2021-08-17
Renewal Date
Applicants
LG CHEM, LTD.
128, Yeoui-daero, Yeongdeungpo-gu, Seoul
07336, Korea
Inventors
1. KIM, Young Kwan
R&D Park, LG Life Sciences Ltd., 188,
Munji-ro, Yuseong-gu, Daejeon 34122,
Republic of Korea
2. PARK, Sang Yun
R&D Park, LG Life Sciences Ltd., 188,
Munji-ro, Yuseong-gu, Daejeon 34122,
Republic of Korea
3. JOO, Hyun Woo
R&D Park, LG Life Sciences Ltd., 188,
Munji-ro, Yuseong-gu, Daejeon 34122,
Republic of Korea
4. CHOI, Eun Sil
R&D Park, LG Life Sciences Ltd., 188,
Munji-ro, Yuseong-gu, Daejeon 34122,
Republic of Korea
5. PAEK, Seung Yup
R&D Park, LG Life Sciences Ltd., 188,
Munji-ro, Yuseong-gu, Daejeon 34122,
Republic of Korea
6. KANG, Seung Wan
R&D Park, LG Life Sciences Ltd., 188,
Munji-ro, Yuseong-gu, Daejeon 34122,
Republic of Korea
7. KIM, Byung Gyu
R&D Park, LG Life Sciences Ltd., 188,
Munji-ro, Yuseong-gu, Daejeon 34122,
Republic of Korea
8. LEE, Chang Seok
R&D Park, LG Life Sciences Ltd., 188,
Munji-ro, Yuseong-gu, Daejeon 34122,
Republic of Korea
9. KIM, Sung Wook
R&D Park, LG Life Sciences Ltd., 188,
Munji-ro, Yuseong-gu, Daejeon 34122,
Republic of Korea
10. LEE, Sang Dae
R&D Park, LG Life Sciences Ltd., 188,
Munji-ro, Yuseong-gu, Daejeon 34122,
Republic of Korea
Specification
Soft copy attached in pdf
Documents
Application Documents
| # | Name | Date |
|---|---|---|
| 1 | 201747025620-TRANSLATIOIN OF PRIOIRTY DOCUMENTS ETC. [19-07-2017(online)].pdf | 2017-07-19 |
| 2 | 201747025620-STATEMENT OF UNDERTAKING (FORM 3) [19-07-2017(online)].pdf | 2017-07-19 |
| 3 | 201747025620-REQUEST FOR EXAMINATION (FORM-18) [19-07-2017(online)].pdf | 2017-07-19 |
| 4 | 201747025620-PRIORITY DOCUMENTS [19-07-2017(online)].pdf | 2017-07-19 |
| 5 | 201747025620-FORM 18 [19-07-2017(online)].pdf | 2017-07-19 |
| 6 | 201747025620-FORM 1 [19-07-2017(online)].pdf | 2017-07-19 |
| 7 | 201747025620-DECLARATION OF INVENTORSHIP (FORM 5) [19-07-2017(online)].pdf | 2017-07-19 |
| 8 | 201747025620-COMPLETE SPECIFICATION [19-07-2017(online)].pdf | 2017-07-19 |
| 9 | 201747025620-CLAIMS UNDER RULE 1 (PROVISIO) OF RULE 20 [19-07-2017(online)].pdf | 2017-07-19 |
| 10 | 201747025620.pdf | 2017-07-21 |
| 11 | 201747025620-Proof of Right (MANDATORY) [28-09-2017(online)].pdf | 2017-09-28 |
| 12 | 201747025620-FORM-26 [28-09-2017(online)].pdf | 2017-09-28 |
| 13 | Correspondence by Agent_Form-1_Power of Attorney_04-10-2017.pdf | 2017-10-04 |
| 14 | 201747025620-FORM 3 [02-01-2018(online)].pdf | 2018-01-02 |
| 15 | 201747025620-RELEVANT DOCUMENTS [21-08-2018(online)].pdf | 2018-08-21 |
| 16 | 201747025620-Changing Name-Nationality-Address For Service [21-08-2018(online)].pdf | 2018-08-21 |
| 17 | 201747025620-FORM-26 [22-08-2018(online)].pdf | 2018-08-22 |
| 18 | 201747025620-FER.pdf | 2019-02-25 |
| 19 | 201747025620-Information under section 8(2) (MANDATORY) [20-08-2019(online)].pdf | 2019-08-20 |
| 20 | 201747025620-FORM 3 [20-08-2019(online)].pdf | 2019-08-20 |
| 21 | 201747025620-OTHERS [23-08-2019(online)].pdf | 2019-08-23 |
| 22 | 201747025620-OTHERS [23-08-2019(online)]-1.pdf | 2019-08-23 |
| 23 | 201747025620-FER_SER_REPLY [23-08-2019(online)].pdf | 2019-08-23 |
| 24 | 201747025620-CLAIMS [23-08-2019(online)].pdf | 2019-08-23 |
| 25 | 201747025620-Correspondence to notify the Controller [06-04-2021(online)].pdf | 2021-04-06 |
| 26 | 201747025620-Written submissions and relevant documents [17-04-2021(online)].pdf | 2021-04-17 |
| 27 | 201747025620-Verified English translation [17-04-2021(online)].pdf | 2021-04-17 |
| 28 | 201747025620-PETITION UNDER RULE 137 [17-04-2021(online)].pdf | 2021-04-17 |
| 29 | 201747025620-PETITION UNDER RULE 137 [17-04-2021(online)]-2.pdf | 2021-04-17 |
| 30 | 201747025620-PETITION UNDER RULE 137 [17-04-2021(online)]-1.pdf | 2021-04-17 |
| 31 | 201747025620-Certified Copy of Priority Document [17-04-2021(online)].pdf | 2021-04-17 |
| 32 | 201747025620-PatentCertificate17-08-2021.pdf | 2021-08-17 |
| 33 | 201747025620-IntimationOfGrant17-08-2021.pdf | 2021-08-17 |
| 34 | 201747025620-US(14)-HearingNotice-(HearingDate-07-04-2021).pdf | 2021-10-17 |
| 35 | 201747025620-RELEVANT DOCUMENTS [09-09-2023(online)].pdf | 2023-09-09 |
Search Strategy
| 1 | SEARCH_11-02-2019.pdf |